Cutaneous T-cell lymphoma represents a complex array of disorders with various manifestations, clinical courses, and therapeutic considerations. Mycosis fungoides — in which the skin is variably ...

Cutaneous T cell lymphomas (CTCL) represent a heterogeneous group of T-cell malignancies that manifest primarily in the skin. By far the most common variant of CTCL is mycosis fungoides and its ...

Please provide your email address to receive an email when new articles are posted on . Topical synthetic hypericin ointment, activated with visible light, shows efficacy in reducing mycosis fungoides ...

This page lists all known medications that could potentially lead to 'Systemic mycosis' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Both mycosis fungoides and Sézary syndrome fall under the umbrella of cutaneous T-cell lymphomas (CTCL), a category of non-Hodgkin lymphomas that greatly impact the skin (cutaneous refers to the skin) ...

Figure 1: Recurrent alterations in T cell survival and activation pathways in mycosis fungoides and Sézary syndrome. Figure 2: Mycosis fungoides and Sézary syndrome are characterized by recurrent ...

In the last few years, there have been scattered reports linking dupilumab with mycosis fungoides. A recent study from the Journal of the American Academy of Dermatology reported a systematic review ...

HUNTINGTON BEACH, California — When patients of Aaron Mangold, MD, first learn they have mycosis fungoides (MF), the most common form of primary cutaneous T-cell lymphoma (CTCL), some are concerned ...

Hypopigmented mycosis fungoides is an uncommon clinical variant of cutaneous T-cell lymphoma. We hypothesized that hypomelanosis in hypopigmented mycosis fungoides may have a similar mechanism as in ...

One day in 2012, when I was a sophomore in high school, I looked in the mirror and was surprised to see light patches on my cheeks that hadn’t been there before. I thought, “Oh my god, what is this?” ...

Dublin, July 31, 2025 (GLOBE NEWSWIRE) -- The "Mycosis Fungoides - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering. The clinical trial report ...

Mycosis fungoides is a type of cutaneous T-cell lymphoma, a cancer caused by abnormal proliferation of a type of white blood cells called T lymphocytes or T-cells and their infiltration into the skin.